Glenmede Trust CO Na Pacific Biosciences Of California, Inc. Transaction History

Glenmede Trust CO Na

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$5.97 - $10.36 $305,383 - $529,945	51,153 New	51,153 $501,000
Q4 2020 Feb 16, 2021	SELL	$10.5 - $28.5 $6,226 - $16,900	-593 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$2.65 - $4.03 $389 - $592	-147 Reduced 19.86%	593 $2,000
Q1 2019 May 14, 2019	SELL	$6.8 - $7.4 $1,271 - $1,383	-187 Reduced 20.17%	740 $5,000
Q4 2018 Feb 14, 2019	BUY	$3.99 - $7.82 $1,332 - $2,611	334 Added 56.32%	927 $6,000
Q2 2018 Aug 15, 2018	BUY	$2.11 - $3.92 $1,251 - $2,324	593 New	593 $2,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.